Literature DB >> 25735544

Gender differences in access to methadone maintenance therapy in a Canadian setting.

Paxton Bach1,2, M-J Milloy1,2, Paul Nguyen1, John Koehn1,2, Silvia Guillemi1, Thomas Kerr1,2, Evan Wood1,2.   

Abstract

INTRODUCTION AND AIMS: Methadone maintenance therapy (MMT) is an evidence-based treatment for opioid addiction. While gender differences in MMT pharmacokinetics, drug use patterns and clinical profiles have been previously described, few studies have compared rates of MMT use among community-recruited samples of persons who inject drugs (PWID). DESIGN AND METHODS: The present study used prospective cohorts of PWID followed between May 1996 and May 2013 in Vancouver, British Columbia, Canada. We investigated potential factors associated with time to methadone initiation using Cox proportional hazards modelling. Stratified analyses were used to examine for gender differences in rates of MMT enrolment.
RESULTS: Overall, 1848 baseline methadone-naïve PWID were included in the study, among whom 595 (32%) were female. In an adjusted model, male gender was independently associated with increased time to MMT initiation and an overall lower rate of enrolment [adjusted relative hazard = 0.74 (95% confidence interval: 0.65-0.85)]. Among both female and male PWID, Caucasian ethnicity and daily injection heroin use were associated with decreased time to methadone initiation, while in females, pregnancy was also associated with more rapid initiation. DISCUSSION AND
CONCLUSIONS: These data highlight gender differences in methadone use among a population of community-recruited PWID. While factors associated with methadone use were similar between genders, rates of use were lower among male PWID, highlighting the need to consider gender when designing strategies to improve recruitment into MMT. [Bach P, Milloy M-J, Nguyen P, Koehn J, Guillemi S, Kerr T, Wood E. Gender differences in access to methadone maintenance therapy in a Canadian setting. Drug Alcohol Rev 2015;34:503-7].
© 2015 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  MMT opiate substitution treatment; gender; intravenous drug abuse; methadone

Year:  2015        PMID: 25735544      PMCID: PMC4573369          DOI: 10.1111/dar.12251

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  22 in total

1.  Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.

Authors:  Sasha Uhlmann; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; David Marsh; Robert S Hogg; Julio S G Montaner; Evan Wood
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

2.  The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).

Authors:  Joanne Ross; Maree Teesson; Shane Darke; Michael Lynskey; Robert Ali; Alison Ritter; Richard Cooke
Journal:  Drug Alcohol Rev       Date:  2005-09

3.  Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

Authors:  Anita Palepu; Mark W Tyndall; Ruth Joy; Thomas Kerr; Evan Wood; Natasha Press; Robert S Hogg; Julio S G Montaner
Journal:  Drug Alcohol Depend       Date:  2006-03-20       Impact factor: 4.492

Review 4.  Implementation of harm reduction in Central and Eastern Europe and Central Asia.

Authors:  Anya Sarang; Raminta Stuikyte; Roman Bykov
Journal:  Int J Drug Policy       Date:  2006-12-19

5.  Challenges in providing drug user treatment services in Russia: providers' views.

Authors:  Natalia Bobrova; Urij Rughnikov; Elena Neifeld; Tim Rhodes; Ron Alcorn; Sergej Kirichenko; Robert Power
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

6.  Pregnancy and race/ethnicity as predictors of motivation for drug treatment.

Authors:  Mary M Mitchell; S Geoff Severtson; William W Latimer
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

7.  Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993.

Authors:  S G Craddock; J L Rounds-Bryant; P M Flynn; R L Hubbard
Journal:  Am J Drug Alcohol Abuse       Date:  1997-02       Impact factor: 3.829

Review 8.  Methadone maintenance at different dosages for opioid dependence.

Authors:  F Faggiano; F Vigna-Taglianti; E Versino; P Lemma
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.

Authors:  H Reddon; M-J Milloy; A Simo; J Montaner; E Wood; T Kerr
Journal:  AIDS Behav       Date:  2014-04

10.  Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010).

Authors:  Allison Carter; Jeong Eun Min; William Chau; Viviane D Lima; Mary Kestler; Neora Pick; Deborah Money; Julio S G Montaner; Robert S Hogg; Angela Kaida
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more
  1 in total

1.  Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: A gender-based analysis.

Authors:  Paxton Bach; Kanna Hayashi; M-J Milloy; Ekaterina Nosova; Thomas Kerr; Evan Wood; Nadia Fairbairn
Journal:  Drug Alcohol Rev       Date:  2020-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.